93 related articles for article (PubMed ID: 2821695)
1. [Is there a relation between the presence in the serum of patients with arterial hypertension of a protein component with molecular weight of 15 kD and the inhibitory effect of the serum on Na,K-ATPase?].
Rogaeva EA; Perova NV; Aleksandrov AA; Oganov RG; Lopina OD
Vopr Med Khim; 1987; 33(4):34-9. PubMed ID: 2821695
[TBL] [Abstract][Full Text] [Related]
2. Reduction of erythrocyte (Na(+)-K+)ATPase activity in type 2 (non-insulin-dependent) diabetic patients with microalbuminuria.
Mimura M; Makino H; Kanatsuka A; Asai T; Yoshida S
Horm Metab Res; 1994 Jan; 26(1):33-8. PubMed ID: 8150421
[TBL] [Abstract][Full Text] [Related]
3. Increased concentrations of a circulating sodium pump inhibitor in essential hypertension and uraemia and its partial purification from haemofiltrate.
Wenzel M; Heidrich E; Kirch U; Moreth-Wolfrat K; Wizemann V; Schoner W
Physiol Bohemoslov; 1990; 39(1):79-85. PubMed ID: 2165269
[TBL] [Abstract][Full Text] [Related]
4. Endogenous inhibitors of the Na+, K(+)-pump and platelet Ca2+ handling in hypertension.
Devynck MA; David-Dufilho M; Astarie C; Mazeaud M; Pernollet MG; Le Quan Sang KH
Physiol Bohemoslov; 1990; 39(1):71-8. PubMed ID: 2165268
[TBL] [Abstract][Full Text] [Related]
5. Endogenous Na+ transport inhibitor in human hypertension: further biochemical and chemical studies.
Cloix JF; Crabos M; Grichois ML; Guicheney P; Meyer P
Klin Wochenschr; 1987; 65 Suppl 8():146-53. PubMed ID: 3037183
[TBL] [Abstract][Full Text] [Related]
6. Recent progress on an endogenous digitalislike factor in hypertension.
Cloix JF; Crabos M; Meyer P
J Clin Hypertens; 1986 Jun; 2(2):93-100. PubMed ID: 3020179
[TBL] [Abstract][Full Text] [Related]
7. [The role of an endogenous digoxin-like factor in regulating blood circulation and in the origin of arrhythmia in myocardial ischemia].
Bagrov AIa; Zhabko EP; Maslova MN; Rukoiatkina NI; Ukhanova MV
Ter Arkh; 1989; 61(7):84-9. PubMed ID: 2555931
[TBL] [Abstract][Full Text] [Related]
8. The role of endogenous Na+, K(+)-adenosine triphosphatase inhibitory factor in the regulation of membrane fluidity of erythrocytes in essential hypertension.
Tsuda K; Shima H; Takeda J; Kimura K; Nishio I; Masuyama Y
J Hypertens; 1992 Jul; 10(7):657-61. PubMed ID: 1321193
[TBL] [Abstract][Full Text] [Related]
9. Volume expansion in renal failure patients: a paradigm for a clinically relevant [Na,K]ATPase inhibitor.
Graves SW; Glatter KA; Lazarus JM; Williams GH; Hollenberg NK
J Cardiovasc Pharmacol; 1993; 22 Suppl 2():S54-7. PubMed ID: 7508029
[TBL] [Abstract][Full Text] [Related]
10. [Changes in the activity of Na+ K+ ATPase in erythrocytes and immunoreactive plasma digoxin-like substances in chronic renal insufficiency: their relation to blood pressure levels].
Widimský J; Horký K; Lachmanová J; Dvoráková J
Vnitr Lek; 1988 Sep; 34(9):843-50. PubMed ID: 2849244
[No Abstract] [Full Text] [Related]
11. [Characterization of an endogenous factor with digitalis-like activity in the heart of the guinea pig (I): Inhibition of Na,K-ATPase)].
Castañeda Hernández G
Arch Inst Cardiol Mex; 1987; 57(2):97-101. PubMed ID: 3038043
[TBL] [Abstract][Full Text] [Related]
12. Plasma endogenous digitalis-like factors in healthy individuals and in dialysis-dependent and kidney transplant patients.
Vasdev S; Johnson E; Longerich L; Prabhakaran VM; Gault MH
Clin Nephrol; 1987 Apr; 27(4):169-74. PubMed ID: 3034459
[TBL] [Abstract][Full Text] [Related]
13. Na-K-ATPase inhibitor dissociated from hypertension-associated plasma protein.
Weiler EW; Khalil-Manesh F; Gonick HC; Prins BA; Purdy RE; Sensharma DK
Am J Hypertens; 1999 Apr; 12(4 Pt 1):364-73. PubMed ID: 10232496
[TBL] [Abstract][Full Text] [Related]
14. [Determination of endoxin in hypertensive patients].
Gorjão Clara J; Breitenfeld B; Bicho M; Moreira C; Carvalho C; Boaventura I; Manso C; Nogueira da Costa J
Rev Port Cardiol; 1991 Jan; 10(1):29-33. PubMed ID: 1647807
[TBL] [Abstract][Full Text] [Related]
15. [Isolation and purification of an endogenous digitalis-like compound. Physiological and pathological role].
Cloix JF; Devynck MA; Meyer P
Rev Med Brux; 1986 Apr; 7(4):201-6. PubMed ID: 3014628
[No Abstract] [Full Text] [Related]
16. [Endogenous digitalis-like factor in liver cirrhosis and cholestasis].
Behrens R; Glauck D; Kaltenborn G; Behrens B; Wache H; Schlee H; Rink C; Böhme I; Nilius R
Z Gastroenterol; 1993 Feb; 31 Suppl 2():20-3. PubMed ID: 7483706
[TBL] [Abstract][Full Text] [Related]
17. Endogenous sodium pump inhibitors in human urine. Further identification of inhibitors of Na-K-ATPase.
Kramer HJ; Krampitz G; Bäcker A; Michel H; Krampitz G; Meyer-Lehnert H
Am J Hypertens; 1995 Jul; 8(7):753-60. PubMed ID: 7546503
[TBL] [Abstract][Full Text] [Related]
18. Endogenous plasma Na,K-ATPase inhibitory activity and digoxin like immunoreactivity after acute myocardial infarction.
Bagrov AYa ; Fedorova OV; Maslova MN; Roukoyatkina NI; Ukhanova MV; Zhabko EP
Cardiovasc Res; 1991 May; 25(5):371-7. PubMed ID: 1649699
[TBL] [Abstract][Full Text] [Related]
19. Digitalis-like substance discovered in human plasma.
Brady SR
Hawaii Med J; 1989 Mar; 48(3):97. PubMed ID: 2543651
[No Abstract] [Full Text] [Related]
20. Acute hypotensive effect of calcium antagonists and endogenous digitalis-like immunoreactivity in human essential hypertension.
Palombo C; Marabotti C; Genovesi-Ebert A; Del Chicca MG; Balzan S; Giaconi S; Fommei E; Gazzetti P; Clerico A; Ghione S
J Hypertens Suppl; 1986 Dec; 4(5):S461-4. PubMed ID: 3033184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
